← Back to ANIP

ANI PHARMACEUTICALS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 08/05/2026Sep 2025Filed 07/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 08/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 08/08/2025Mar 2024Filed 09/05/2025
$266$237$228$211$197$148$138$137
$25$29$27$8.5$16−$24−$2.3$18
$1.05$1.28$1.13$0.36$0.69−$1.27−$0.14$0.82
2222212020191919

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.